Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC

Hyperlipidemia is defined as the presence of either hypertriglyceridemia or hypercholesterolemia, which could cause atherosclerosis. Although hyperlipidemia can be treated by hypolipidemic drugs, they are limited due to lack of effectiveness and safety. Previous studies demonstrated that xanthorrhiz...

Full description

Bibliographic Details
Main Authors: Oon, Seok Fang, Nallappan, Meenakshii, Kassim, Nur Kartinee, Shohaimi, Shamarina, Sa'ariwijaya, Mohd Shazrul Fazry, Tee, Thiam Tsui, Cheah, Yew Hoong
Format: Article
Language:English
Published: Elsevier 2016
Subjects:
Online Access:http://psasir.upm.edu.my/id/eprint/54474/1/Hypolipidemic%20activities%20of%20xanthorrhizol%20purified%20from%20centrifugal%20TLC.pdf
_version_ 1825931044586520576
author Oon, Seok Fang
Nallappan, Meenakshii
Kassim, Nur Kartinee
Shohaimi, Shamarina
Sa'ariwijaya, Mohd Shazrul Fazry
Tee, Thiam Tsui
Cheah, Yew Hoong
author_facet Oon, Seok Fang
Nallappan, Meenakshii
Kassim, Nur Kartinee
Shohaimi, Shamarina
Sa'ariwijaya, Mohd Shazrul Fazry
Tee, Thiam Tsui
Cheah, Yew Hoong
author_sort Oon, Seok Fang
collection UPM
description Hyperlipidemia is defined as the presence of either hypertriglyceridemia or hypercholesterolemia, which could cause atherosclerosis. Although hyperlipidemia can be treated by hypolipidemic drugs, they are limited due to lack of effectiveness and safety. Previous studies demonstrated that xanthorrhizol (XNT) isolated from Curcuma xanthorrhizza Roxb. reduced the levels of free fatty acid and triglyceride in vivo. However, its ability to inhibit cholesterol uptake in HT29 colon cells and adipogenesis in 3T3-L1 cells are yet to be reported. In this study, XNT purified from centrifugal TLC demonstrated 98.3% purity, indicating it could be an alternative purification method. The IC50 values of XNT were 30.81 ± 0.78 μg/mL in HT29 cells and 35.07 ± 0.24 μg/mL in 3T3-L1 adipocytes, respectively. Cholesterol uptake inhibition study using HT29 colon cells showed that XNT (15 μg/mL) significantly inhibited the fluorescent cholesterol analogue NBD uptake by up to 27 ± 3.1% relative to control. On the other hand, higher concentration of XNT (50 μg/mL) significantly suppressed the growth of 3T3-L1 adipocytes (5.9 ± 0.58%) compared to 3T3-L1 preadipocytes (81.31 ± 0.55%). XNT was found to impede adipogenesis of 3T3-L1 adipocytes in a dose-dependent manner from 3.125 to 12.5 μg/mL, where 12.5 μg/mL significantly suppressed 36.13 ± 2.1% of lipid accumulation. We postulate that inhibition of cholesterol uptake, adipogenesis, preadipocyte and adipocyte number may be utilized as treatment modalities to reduce the prevalence of lipidemia. To conclude, XNT could be a potential hypolipidemic agent to improve cardiovascular health in the future.
first_indexed 2024-03-06T09:20:46Z
format Article
id upm.eprints-54474
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T09:20:46Z
publishDate 2016
publisher Elsevier
record_format dspace
spelling upm.eprints-544742018-03-20T01:10:02Z http://psasir.upm.edu.my/id/eprint/54474/ Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC Oon, Seok Fang Nallappan, Meenakshii Kassim, Nur Kartinee Shohaimi, Shamarina Sa'ariwijaya, Mohd Shazrul Fazry Tee, Thiam Tsui Cheah, Yew Hoong Hyperlipidemia is defined as the presence of either hypertriglyceridemia or hypercholesterolemia, which could cause atherosclerosis. Although hyperlipidemia can be treated by hypolipidemic drugs, they are limited due to lack of effectiveness and safety. Previous studies demonstrated that xanthorrhizol (XNT) isolated from Curcuma xanthorrhizza Roxb. reduced the levels of free fatty acid and triglyceride in vivo. However, its ability to inhibit cholesterol uptake in HT29 colon cells and adipogenesis in 3T3-L1 cells are yet to be reported. In this study, XNT purified from centrifugal TLC demonstrated 98.3% purity, indicating it could be an alternative purification method. The IC50 values of XNT were 30.81 ± 0.78 μg/mL in HT29 cells and 35.07 ± 0.24 μg/mL in 3T3-L1 adipocytes, respectively. Cholesterol uptake inhibition study using HT29 colon cells showed that XNT (15 μg/mL) significantly inhibited the fluorescent cholesterol analogue NBD uptake by up to 27 ± 3.1% relative to control. On the other hand, higher concentration of XNT (50 μg/mL) significantly suppressed the growth of 3T3-L1 adipocytes (5.9 ± 0.58%) compared to 3T3-L1 preadipocytes (81.31 ± 0.55%). XNT was found to impede adipogenesis of 3T3-L1 adipocytes in a dose-dependent manner from 3.125 to 12.5 μg/mL, where 12.5 μg/mL significantly suppressed 36.13 ± 2.1% of lipid accumulation. We postulate that inhibition of cholesterol uptake, adipogenesis, preadipocyte and adipocyte number may be utilized as treatment modalities to reduce the prevalence of lipidemia. To conclude, XNT could be a potential hypolipidemic agent to improve cardiovascular health in the future. Elsevier 2016-09 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/54474/1/Hypolipidemic%20activities%20of%20xanthorrhizol%20purified%20from%20centrifugal%20TLC.pdf Oon, Seok Fang and Nallappan, Meenakshii and Kassim, Nur Kartinee and Shohaimi, Shamarina and Sa'ariwijaya, Mohd Shazrul Fazry and Tee, Thiam Tsui and Cheah, Yew Hoong (2016) Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC. Biochemical and Biophysical Research Communications, 478 (3). pp. 1403-1408. ISSN 0006-291X; ESSN: 1090-2104 https://www.sciencedirect.com/science/article/pii/S0006291X16314000 Xanthorrhizol; Centrifugal TLC; HT29 colon cells; 3T3-L1 adipocytes; Cholesterol; Adipogenesis 10.1016/j.bbrc.2016.08.136
spellingShingle Xanthorrhizol; Centrifugal TLC; HT29 colon cells; 3T3-L1 adipocytes; Cholesterol; Adipogenesis
Oon, Seok Fang
Nallappan, Meenakshii
Kassim, Nur Kartinee
Shohaimi, Shamarina
Sa'ariwijaya, Mohd Shazrul Fazry
Tee, Thiam Tsui
Cheah, Yew Hoong
Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC
title Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC
title_full Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC
title_fullStr Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC
title_full_unstemmed Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC
title_short Hypolipidemic activities of xanthorrhizol purified from centrifugal TLC
title_sort hypolipidemic activities of xanthorrhizol purified from centrifugal tlc
topic Xanthorrhizol; Centrifugal TLC; HT29 colon cells; 3T3-L1 adipocytes; Cholesterol; Adipogenesis
url http://psasir.upm.edu.my/id/eprint/54474/1/Hypolipidemic%20activities%20of%20xanthorrhizol%20purified%20from%20centrifugal%20TLC.pdf
work_keys_str_mv AT oonseokfang hypolipidemicactivitiesofxanthorrhizolpurifiedfromcentrifugaltlc
AT nallappanmeenakshii hypolipidemicactivitiesofxanthorrhizolpurifiedfromcentrifugaltlc
AT kassimnurkartinee hypolipidemicactivitiesofxanthorrhizolpurifiedfromcentrifugaltlc
AT shohaimishamarina hypolipidemicactivitiesofxanthorrhizolpurifiedfromcentrifugaltlc
AT saariwijayamohdshazrulfazry hypolipidemicactivitiesofxanthorrhizolpurifiedfromcentrifugaltlc
AT teethiamtsui hypolipidemicactivitiesofxanthorrhizolpurifiedfromcentrifugaltlc
AT cheahyewhoong hypolipidemicactivitiesofxanthorrhizolpurifiedfromcentrifugaltlc